Literature DB >> 25055628

A chicken embryo lethality assay for pathogenic Enterococcus cecorum.

Luke B Borst, M Mitsu Suyemoto, Shivaramu Keelara, Sarah E Dunningan, James S Guy, H John Barnes.   

Abstract

Pathogenic strains of Enterococcus cecorum cause outbreaks of arthritis and osteomyelitis in chickens worldwide. Enterococcal spondylitis (ES) is a specific manifestation of E. cecorum-associated disease of broilers and broiler breeders characterized by increased flock mortality, resulting from unresolved infection of the free thoracic vertebra by pathogenic E. cecorum. A study of 22 ES outbreaks in the southeast United States revealed that pathogenic E. cecorum strains isolated from spinal lesions were genetically clonal. Here, we compare the virulence of previously genotyped pathogenic strains (n = 8) isolated from spinal lesions and nonpathogenic strains (n = 9) isolated from ceca of unaffected birds in a chicken embryo lethality model. Strains were inoculated into the allantoic cavity of 12-day-old broiler and specific-pathogen-free (SPF) layer embryos; embryo survival was determined by candling eggs daily for 4 days. Significantly decreased survival occurred in both broiler and SPF embryos inoculated with pathogenic genotype strains compared with embryos inoculated with nonpathogenic genotype strains (broiler embryos, 23% vs. 60%; SPF embryos, 9% vs. 61%). Embryos infected with pathogenic strains were unable to control infection and consistently showed gross changes typical of sepsis, including hemorrhage and edema. After 48 hr, similar changes were not observed in embryos infected with nonpathogenic strains. This embryo lethality assay provides a useful tool for understanding the genetic basis of E. cecorum virulence.

Entities:  

Mesh:

Year:  2014        PMID: 25055628     DOI: 10.1637/10687-101113-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  7 in total

1.  Chicken embryo lethality assay for determining the lethal dose, tissue distribution and pathogenicity of clinical Enterococcus cecorum isolates from poultry.

Authors:  Beata Dolka; Michał Czopowicz; Izabella Dolka; Piotr Szeleszczuk
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

2.  Comparative genomic analysis identifies divergent genomic features of pathogenic Enterococcus cecorum including a type IC CRISPR-Cas system, a capsule locus, an epa-like locus, and putative host tissue binding proteins.

Authors:  Luke B Borst; M Mitsu Suyemoto; Elizabeth H Scholl; Fredrick J Fuller; H John Barnes
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

3.  Characterization of pathogenic Enterococcus cecorum from different poultry groups: Broiler chickens, layers, turkeys, and waterfowl.

Authors:  Beata Dolka; Dorota Chrobak-Chmiel; Michał Czopowicz; Piotr Szeleszczuk
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

4.  Comparison of pathogenic and non-pathogenic Enterococcus cecorum strains from different animal species.

Authors:  Arne Jung; Martin Metzner; Martin Ryll
Journal:  BMC Microbiol       Date:  2017-02-13       Impact factor: 3.605

5.  Genomic Characterization of a Nalidixic Acid-Resistant Salmonella Enteritidis Strain Causing Persistent Infections in Broiler Chickens.

Authors:  Grayson K Walker; M Mitsu Suyemoto; Dawn M Hull; Sesny Gall; Fernando Jimenez; Laura R Chen; Siddhartha Thakur; Rocio Crespo; Luke B Borst
Journal:  Front Vet Sci       Date:  2021-09-01

6.  Different virulence levels of Enterococcus cecorum strains in experimentally infected meat-type chickens.

Authors:  Jana Schreier; Silke Rautenschlein; Arne Jung
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

7.  Presence of Virulence Genes in Enterococcus Species Isolated from Meat Turkeys in Germany Does Not Correlate with Chicken Embryo Lethality.

Authors:  Julia Maasjost; Dörte Lüschow; Anne Kleine; Hafez M Hafez; Kristin Mühldorfer
Journal:  Biomed Res Int       Date:  2019-10-30       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.